Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Support MFO
Donate through PayPal
iShares Nasdaq Biotech Index See Record Record $372M Redemption
There might be a good technical trade opportunity coming up for IBB to get in.
Set up stop (219) limit (225) buy and if that executes a stop sell at around 216 in case it breaks through the 200 SMA with a broad market decline. Upside 8% to 20%+. Downside 4-5%.
Comments
Set up stop (219) limit (225) buy and if that executes a stop sell at around 216 in case it breaks through the 200 SMA with a broad market decline. Upside 8% to 20%+. Downside 4-5%.
High potential for a low around 220.